John M. McLaughlin
John M. McLaughlin publishes mostly in Infectious Diseases, Epidemiology and Health, on topics such as SARS-CoV-2 and COVID-19 Research, Vaccine Coverage and Hesitancy and COVID-19 Clinical Research Studies.
- World rank
- #88,993 of 7,710,434 ranked researchers
- Rank in United States
- #34,361 of 1,627,098
- Works
- 162
- Citations
- 7.7k
- Citations per work
- 47.7
What does John M. McLaughlin research?
John M. McLaughlin's work is mostly in Medicine (50%), Social Sciences (10%), Immunology and Microbiology (5%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences8149.7%
- Medicine8149.7%
- Everything else5031.1%
- Social Sciences1710.3%
- Social Sciences1710.3%
- Life Sciences84.9%
- Physical Sciences64.0%
- Mathematics64.0%
- 1Infectious Diseases30% of their works
- 2Epidemiology17% of their works
- 3Health10% of their works
- 4Immunology5% of their works
- 5Modeling and Simulation4% of their works
- 6Oncology3% of their works
Research topics
Which keywords describe John M. McLaughlin's research?
The keywords of their largest research topics: ACE2 Receptor, SARS-CoV-2, Epidemiology, Coronavirus, Vaccine, COVID-19 Vaccine, Vaccine Hesitancy and Clinical Characteristics.
- Post-acute COVID-19 Syndrome
- Modeling
- Trained Immunity
- Pneumococcal Conjugate Vaccine
- Respiratory Syncytial Virus
- Infectious Diseases
- Clinical Characteristics
- COVID-19 Vaccine
- Coronavirus
- SARS-CoV-2
- ACE2 Receptor
- Epidemiology
- Vaccine
- Vaccine Hesitancy
- Thrombosis
- Human Metapneumovirus
- Community-Acquired Pneumonia
- Innate Memory
- COVID-19
- Neurologic Manifestations
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 20 words, with their numbers
- ACE2 Receptor1182 topics
- SARS-CoV-21182 topics
- Epidemiology1104 topics
- Coronavirus761 topic
- Vaccine761 topic
- COVID-19 Vaccine461 topic
- Vaccine Hesitancy461 topic
- Clinical Characteristics421 topic
- Thrombosis421 topic
- Infectious Diseases372 topics
- Human Metapneumovirus271 topic
- Respiratory Syncytial Virus271 topic
- Community-Acquired Pneumonia231 topic
- Pneumococcal Conjugate Vaccine231 topic
- Innate Memory191 topic
- Trained Immunity191 topic
- COVID-19181 topic
- Modeling181 topic
- Neurologic Manifestations121 topic
- Post-acute COVID-19 Syndrome121 topic
Where does John M. McLaughlin work?
John M. McLaughlin's main affiliation in the publication record is Pfizer (United States), United States.
How many publications and citations does John M. McLaughlin have?
OpenAlex counts 162 works and 7,725 citations for John M. McLaughlin, an h-index of 38, ranking #88,993 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about John M. McLaughlin. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.